Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • News
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • News
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Rabbit Polyclonals
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Rabbit Polyclonals

[0399-CSB-PA019041GA01HU-150] PTPN4 Polyclonal Antibody - 150 uL
PTPN4 Polyclonal Antibody - 150 uL
650.00 € 650.0 EUR
[0772-BT-AP07482-50UL] PTN Polyclonal Antibody - 50 ul
PTN Polyclonal Antibody - 50 ul
262.00 € 262.0 EUR
[0772-BT-AP07482-20UL] PTN Polyclonal Antibody - 20 ul
PTN Polyclonal Antibody - 20 ul
198.00 € 198.0 EUR
[0763-E-AB-12628-120] PRDX3 Polyclonal Antibody - 120 uL
PRDX3 Polyclonal Antibody - 120 uL
355.00 € 355.0 EUR
[0763-E-AB-16705-200μL] PPARGC1B Polyclonal Antibody-200μL
PPARGC1B Polyclonal Antibody-200μL
750.00 € 750.0 EUR
[0806-A17285-20] PIM3 Rabbit pAb, 20uL
PIM3 Rabbit pAb, 20uL
190.00 € 190.0 EUR
[0812-SL17581R-100UL] Oxytocin polyclonal antibody - 100 uL
Oxytocin polyclonal antibody - 100 uL
363.00 € 363.0 EUR
[0772-BT-AP11582-50UL] NSUN7 Rabbit Polyclonal Antibody,50ul
NSUN7 Rabbit Polyclonal Antibody,50ul
308.00 € 308.0 EUR
[0356-A60028-050] NKG7 Polyclonal Antibody, FITC Conjug.ated 50ul
NKG7 Polyclonal Antibody, FITC Conjug.ated 50ul
509.00 € 509.0 EUR
[0356-A60028-0100] NKG7 Polyclonal Antibody, FITC Conjug.ated 100ul
NKG7 Polyclonal Antibody, FITC Conjug.ated 100ul
633.00 € 633.0 EUR
[0544-MBS9463393] NG2 Polyclonal Antibody FITC Conjug.ated, 0,1 ml
NG2 Polyclonal Antibody FITC Conjug.ated, 0,1 ml
785.00 € 785.0 EUR
[0544-MBS260718-96T] NF-kappaB elisa Test :: Human Nuclear Factor Kappa B (NF-kappaB) ELISA Test, 96 test
NF-kappaB elisa Test :: Human Nuclear Factor Kappa B (NF-kappaB) ELISA Test, 96 test
619.00 € 619.0 EUR
[0544-MBS260718-48T] NF-kappaB elisa Test :: Human Nuclear Factor Kappa B (NF-kappaB) ELISA Test, 48 T
NF-kappaB elisa Test :: Human Nuclear Factor Kappa B (NF-kappaB) ELISA Test, 48 T
465.00 € 465.0 EUR
[0544-MBS260718-10x96] NF-kappaB elisa Test :: Human Nuclear Factor Kappa B (NF-kappaB) ELISA Test, 10X96 test
NF-kappaB elisa Test :: Human Nuclear Factor Kappa B (NF-kappaB) ELISA Test, 10X96 test
3,979.00 € 3979.0 EUR
[0806-A2547-20] NF-kB p65/RelA Rabbit pAb, 20uL
NF-kB p65/RelA Rabbit pAb, 20uL
190.00 € 190.0 EUR
[0894-AB8181-200] tdTomato Goat Polyclonal Antibody, 600ug.
tdTomato Goat Polyclonal Antibody, 600ug.
442.00 € 442.0 EUR
[0820-PVT12961] pET15b-PABPC1 Plasmid - 2 µg
pET15b-PABPC1 Plasmid - 2 µg
865.00 € 865.0 EUR
nNOS:C-Terminal (neuronal Nitric Oxide Synthase) Polyclonal Antibody - 100ul
nNOS:C-Terminal (neuronal Nitric Oxide Synthase) Polyclonal Antibody - 100ul
582.00 € 582.0 EUR
[0894-SCG-AB5421] mApple Polyclonal Antibody - 300µg
mApple Polyclonal Antibody - 300µg
442.00 € 442.0 EUR
[0498-BS-9585R] gamma crystallin S Polyclonal Antibody - 100ul
gamma crystallin S Polyclonal Antibody - 100ul
600.00 € 600.0 EUR
  • 12
  • 13
  • 14
  • 15
  • 16

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)